{"patient_id": "P001", "mrn": "MDA-1001", "source": "Source-C", "oncologist_id": "ONC-C", "oncologist_name": "Dr. Chen", "note_datetime": "2025-07-12T13:00:00", "section": "Treatment", "text": "Pathology: ovary biopsy invasive ductal carcinoma. Markers: KRAS G12D; TP53 mut; MSI-stable.", "provenance": {"ingested_from": "/sources/C/P001.txt", "checksum": "0x46a02a9b65ec7acd"}}
{"patient_id": "P001", "mrn": "MDA-1001", "source": "Source-C", "oncologist_id": "ONC-C", "oncologist_name": "Dr. Chen", "note_datetime": "2023-12-03T10:00:00", "section": "Assessment/Plan", "text": "Imaging report: MRI brain shows progression in mediastinal nodes. RECIST target PR.", "provenance": {"ingested_from": "/sources/C/P001.txt", "checksum": "0xdbc080fd46fb7bf3"}}
{"patient_id": "P001", "mrn": "MDA-1001", "source": "Source-C", "oncologist_id": "ONC-C", "oncologist_name": "Dr. Chen", "note_datetime": "2023-04-27T09:45:00", "section": "Treatment", "text": "Treatment note: Started Gem/Nab-Paclitaxel cycle 5. Premeds given. Tolerated poorly (dose reduce).", "provenance": {"ingested_from": "/sources/C/P001.txt", "checksum": "0xc72c1fe372c22a16"}}
{"patient_id": "P002", "mrn": "MDA-1002", "source": "Source-C", "oncologist_id": "ONC-C", "oncologist_name": "Dr. Chen", "note_datetime": "2023-11-26T10:00:00", "section": "HPI", "text": "Clinic note: NSCLC, adenocarcinoma. Staging IV. ECOG 0. Weight 78kg. fatigue grade 2. Plan: consider gemcitabine/nab-paclitaxel.", "provenance": {"ingested_from": "/sources/C/P002.txt", "checksum": "0x466772ce204e178c"}}
{"patient_id": "P002", "mrn": "MDA-1002", "source": "Source-C", "oncologist_id": "ONC-C", "oncologist_name": "Dr. Chen", "note_datetime": "2024-03-01T09:30:00", "section": "Pathology", "text": "Treatment note: Started FOLFIRINOX cycle 6. Premeds given. Tolerated with nausea.", "provenance": {"ingested_from": "/sources/C/P002.txt", "checksum": "0x50018b7b6d4067f4"}}
